Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Pharmaceuticals (Basel, Switzerland)|July 27, 2022
Synthesis and Biological Evaluation of Imadazo[1,2-a]pyrazines as Anticancer and Antiviral Agents through Inhibition of CDK9 and Human CoronavirusAisha A Alsfouk, Hanan M Alshibl, Bshra A Alsfouk, et al.
RSC Advances|February 24, 2025
Design, synthesis, molecular docking and anticancer activity of benzothiazolecarbohydrazide-sulfonate conjugates: insights into ROS-induced DNA damage and tubulin polymerization inhibitionNajla A Altwaijry, Mohamed A Omar, Hanaa S Mohamed, et al.
Pharmaceuticals (Basel, Switzerland)|July 29, 2023
New Imadazopyrazines with CDK9 Inhibitory Activity as Anticancer and Antiviral: Synthesis, In Silico, and In Vitro Evaluation ApproachesAisha A Alsfouk, Hanan M Alshibl, Najla A Altwaijry, et al.
Future Medicinal Chemistry|November 24, 2024
New pyrano-pyridine conjugates as potential anticancer agents: design, synthesis and computational studiesAladdin M Srour, Eman S Nossier, Najla A Altwaijry, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|May 29, 2026
Design, synthesis, anticancer activity, and mechanistic investigation of 4,5,6,7-tetrahydrobenzo[b]thiophene carboxamides as CDK-2 inhibitors: in vitro and in silico DFT and molecular docking studyKurls E Anwer, Ramadan M Ramadan, Eman S Nossier, et al.
RSC Advances|March 16, 2026
Development, anti-proliferative activity, multi-target kinase inhibition against CHK1, PIM1, and CDK-2, and computational insights of new thiazole-based hybridsNajla A Altwaijry, Ismail M M Othman, Manal M Anwar, et al.
RSC Advances|January 14, 2025
New quinazolone-sulfonate conjugates with an acetohydrazide linker as potential antimicrobial agents: design, synthesis and molecular docking simulationsAsmaa F Kassem, Sherif S Ragab, Mohamed A Omar, et al.
BMC Medical Education|February 3, 2025
Insights into simulation-based learning: student and faculty experiences in a PharmD program in Saudi ArabiaReem Binsuwaidan, Najla A Altwaijry, Alnada A Ibrahim, et al.
Frontiers in Oncology|January 2, 2023
The integrative bioinformatics approaches to predict the xanthohumol as anti-breast cancer molecule: Targeting cancer cells signaling PI3K and AKT kinase pathwayKartikey Kumar Gupta, Kamal Kant Sharma, Harish Chandra, et al.
Pharmaceuticals (Basel, Switzerland)|October 29, 2025
Innovative Amino-Functionalization of Pyrido[2,3-d]pyrimidine Scaffolds for Broad Therapeutic Applications Supported by Computational AnalysesHagar S El-Hema, Haitham E Shehata, Mohamed A Hawata, et al.
Pageof 2